[1]
F. V. K. Gabriel, “USE OF DUAL AND TRIPLE INCRETIN AGONISTS (TIRZEPATIDE AND RETATRUTIDE) IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS ”, Editora, pp. 174–183, Apr. 2026, doi: 10.56238/sevened2026.020-013.